Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002627364 | SCV002971072 | uncertain significance | Pigmentary pallidal degeneration | 2022-08-11 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu567*) in the PANK2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 4 amino acid(s) of the PANK2 protein. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with PANK2-related conditions. This variant disrupts a region of the PANK2 protein in which other variant(s) (p.Pro570Leu) have been observed in individuals with PANK2-related conditions (PMID: 20629144). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |